Fidelity Investments’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.8M | Buy |
|
|||||
|
2025
Q1 | $23.1M | Buy |
|
|||||
|
2024
Q4 | $17.1M | Sell |
|
|||||
|
2024
Q3 | $20.4M | Buy |
|
|||||
|
2024
Q2 | $15.1M | Sell |
|
|||||
|
2024
Q1 | $13.5M | Buy |
|
|||||
|
2023
Q4 | $10.7M | Sell |
|
|||||
|
2023
Q3 | $8.49M | Buy |
|
|||||
|
2023
Q2 | $14M | Buy |
|
|||||
|
2023
Q1 | $1.11M | Sell |
|
|||||
|
2022
Q4 | $748K | Sell |
|
|||||
|
2022
Q3 | $23.7M | Sell |
|
|||||
|
2022
Q2 | $27.6M | Sell |
|
|||||
|
2022
Q1 | $169M | Buy |
|
|||||
|
2021
Q4 | $234M | Buy |
|
|||||
|
2021
Q3 | $115M | Sell |
|
|||||
|
2021
Q2 | $319M | Buy |
|
|||||
|
2021
Q1 | $170M | Buy |
|
|||||
|
2020
Q4 | $130M | Buy |
|
|||||
|
2020
Q3 | $102M | Buy |
|
|||||
|
2020
Q2 | $91.2M | Buy |
|
|||||
|
2020
Q1 | $28.9M | Buy |
|
|||||
|
2019
Q4 | $28.8M | Buy |
|
|||||
|
2019
Q3 | $47.3M | Buy |
|
|||||
|
2019
Q2 | $42.5M | Sell |
|
|||||
|
2019
Q1 | $45.3M | Sell |
|
|||||
|
2018
Q4 | $24.4M | Buy |
|
|||||
|
2018
Q3 | $35.6M | Buy |
|
|||||
|
2018
Q2 | $21.4M | Buy |
|
|||||
|
2018
Q1 | $27.2M | Buy |
|
|||||
|
2017
Q4 | $63.9M | Buy |
|
|||||
|
2017
Q3 | $44.8M | Buy |
|
|||||
|
2017
Q2 | $28.6M | Buy |
|
|||||
|
2017
Q1 | $32.3M | Buy |
|
|||||
|
2016
Q4 | $55.1M | Buy |
|
|||||
|
2016
Q3 | $45M | Buy |
|